Patient recruitment

Nordic Nanovector Announces Focus on Advancing PARADIGME and Actions to Extend Cash Runway into 2021

Wednesday, April 1, 2020 - 4:29pm

OSLO, Norway, April 1, 2020 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) today announces a number of initiatives to speed up recruitment into its pivotal Phase 2b PARADIGME trial with Betalutin in advanced follicular lymphoma (FL) as well as to extend its cash runway into 2021.

Key Points: 
  • OSLO, Norway, April 1, 2020 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) today announces a number of initiatives to speed up recruitment into its pivotal Phase 2b PARADIGME trial with Betalutin in advanced follicular lymphoma (FL) as well as to extend its cash runway into 2021.
  • Following this assessment several key development decisions have been made:
    Intend to broaden PARADIGME's inclusion criteria to increase rate of recruitment.
  • Nordic Nanovector still plans a rolling submission for Betalutin with FDA once it has the top line data from the PARADIGME trial.
  • Commenting on today's announcement, Lars Nieba, Interim CEO of Nordic Nanovector, said: "The actions that we have announced today are designed to significantly improve patient recruitment into our pivotal Phase 2b PARADIGME trial with Betalutin and to extend our cash runway into 2021.

Nordic Nanovector Announces Focus on Advancing PARADIGME and Actions to Extend Cash Runway into 2021

Wednesday, April 1, 2020 - 4:27pm

OSLO, Norway, April 1, 2020 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) today announces a number of initiatives to speed up recruitment into its pivotal Phase 2b PARADIGME trial with Betalutin in advanced follicular lymphoma (FL) as well as to extend its cash runway into 2021.

Key Points: 
  • OSLO, Norway, April 1, 2020 /PRNewswire/ -- Nordic Nanovector ASA (OSE: NANO) today announces a number of initiatives to speed up recruitment into its pivotal Phase 2b PARADIGME trial with Betalutin in advanced follicular lymphoma (FL) as well as to extend its cash runway into 2021.
  • Following this assessment several key development decisions have been made:
    Intend to broaden PARADIGME's inclusion criteria to increase rate of recruitment.
  • Nordic Nanovector still plans a rolling submission for Betalutin with FDA once it has the top line data from the PARADIGME trial.
  • Commenting on today's announcement, Lars Nieba, Interim CEO of Nordic Nanovector, said: "The actions that we have announced today are designed to significantly improve patient recruitment into our pivotal Phase 2b PARADIGME trial with Betalutin and to extend our cash runway into 2021.

Clinical Trial Media Introduces New Website, Covid19ClinicalTrial.com

Tuesday, March 31, 2020 - 1:38pm

HAUPPAUGE, N.Y., March 31, 2020 /PRNewswire/ --Clinical Trial Media, a data-driven, global patient recruitment and retention company offering a wide variety of services for clinical trials, announced the debut of a new website, Covid19ClinicalTrial.com .

Key Points: 
  • HAUPPAUGE, N.Y., March 31, 2020 /PRNewswire/ --Clinical Trial Media, a data-driven, global patient recruitment and retention company offering a wide variety of services for clinical trials, announced the debut of a new website, Covid19ClinicalTrial.com .
  • "With so much misinformation going around about COVID-19, I felt it necessary to create a centralized, trusted resource for all information related to Coronavirus clinical research," said Cara Brant, CEO of Clinical Trial Media.
  • "Having a single source for trustworthy information is so important to people who are already confused and scared enough about COVID-19 and need reassurance and facts they can trust," said Andrew Pollack, VP of Marketing for Clinical Trial Media.
  • For more information about the work being done by Clinical Trial Media, visit www.clinicaltrialmedia.com .

ClinOne’s Remote Clinical Trial Patient Management Technology Allows Pharmaceutical Companies to Continue Clinical Research Efforts Amidst the Covid-19 Pandemic in Accordance with FDA Guidelines

Wednesday, March 25, 2020 - 7:46pm

This need is especially acute in clinical trials as identified by the FDA.

Key Points: 
  • This need is especially acute in clinical trials as identified by the FDA.
  • Trial sponsors, physicians and regulators are now embracing the use of technology to support patients and sites involved in clinical trials in ways needed to preserve the viability of the worldwide clinical trial system.
  • The FDA's newly published guidance on conducting clinical trials during the Covid-19 pandemic advocates for remote patient management and virtual study visits.
  • The ClinOne solution and its suite of products were created to improve clinical trial enrollment and remote patient compliance.

UCHealth Leads Investment Into ClinOne – a Remote Clinical Trial Patient Management Technology Company

Tuesday, March 24, 2020 - 10:32pm

Through the ClinOne and ClinTrialConnect platforms, the company allows pharmaceutical sponsors, research sites and clinical trial participants to perform and automate key clinical trial operational tasks including clinical trial recruitment, study execution, compliance and patient retention from any location world-wide.

Key Points: 
  • Through the ClinOne and ClinTrialConnect platforms, the company allows pharmaceutical sponsors, research sites and clinical trial participants to perform and automate key clinical trial operational tasks including clinical trial recruitment, study execution, compliance and patient retention from any location world-wide.
  • ClinOnes modules span patient recruitment, remote consent (eConsent), patient reported outcomes and surveys (ePRO), dosing management, remote vital sign management data collection and seamlessly integrates with home healthcare visits and telemedicine video visits.
  • ClinOnes recent partnership with our portfolio company BioIntelliSense, as an example ,will enable remote patient monitoring to come to clinical trial management in more robust ways.
  • The ClinOne solution and its suite of products were created to improve clinical trial enrollment and remote patient compliance.

US clinical trial site concerns over COVID-19 impact on enrollment jumps by 124% over past week

Monday, March 23, 2020 - 8:35pm

Clinical trial sites in Europe who responded to the survey continue to indicate a higher level of concern overall, with nearly 85% of sites indicating the pandemic will negatively impact clinical trial enrollment.

Key Points: 
  • Clinical trial sites in Europe who responded to the survey continue to indicate a higher level of concern overall, with nearly 85% of sites indicating the pandemic will negatively impact clinical trial enrollment.
  • (Graphic: Business Wire)
    On March 20, Continuum Clinical, a global clinical trial enrollment company specializing in fact-based strategies, gathered follow up results from their survey fielded previously on March 13 and 17.
  • Continuum Clinical is a global clinical trial enrollment company, providing fact-based patient recruitment solutions that deliver results.
  • We specialize in identifying and solving challenges that can impact successful clinical trial enrollment, from protocol development through study completion.

US Clinical Trial Site Concerns Over COVID-19 Impact on Enrollment Jumps by 88% in Just 4 Days

Wednesday, March 18, 2020 - 5:56pm

Clinical trial sites in Europe who responded to the survey indicated a higher level of concern overall, with nearly 80% of sites indicating the pandemic will negatively impact clinical trial enrollment.

Key Points: 
  • Clinical trial sites in Europe who responded to the survey indicated a higher level of concern overall, with nearly 80% of sites indicating the pandemic will negatively impact clinical trial enrollment.
  • (Graphic: Business Wire)
    On March 17, Continuum Clinical, a global clinical trial enrollment company specializing in fact-based strategies, gathered follow up results from their original March 13 survey.
  • Continuum Clinical is a global clinical trial enrollment company, providing fact-based patient recruitment solutions that deliver results.
  • We specialize in identifying and solving challenges that can impact successful clinical trial enrollment, from protocol development through study completion.

Insights on the Global Clinical Trials Market Analysis 2019 - ResearchAndMarkets.com

Wednesday, March 18, 2020 - 11:26am

The "Global Clinical Trials Market Analysis 2019" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Global Clinical Trials Market Analysis 2019" report has been added to ResearchAndMarkets.com's offering.
  • The Global Clinical Trials market is expected to reach $69.41 billion by 2026 growing at a CAGR of 7.8% during 2018 to 2026.
  • A clinical trial is a type of research that studies a test or treatment given to people.
  • Clinical trials study how safe and helpful tests and treatments are.

Survey Indicates COVID-19 to Negatively Impact Clinical Trial Enrollment and Retention

Monday, March 16, 2020 - 9:45pm

(Graphic: Business Wire)

Key Points: 
  • (Graphic: Business Wire)
    Continuum Clinical, a global clinical trial enrollment company specializing in fact-based strategies, conducted the quantitative study on March 12-13 with 170 clinical trial sites in the US.
  • Initial results indicate multiple areas of concern for study sites, highlighting an expected significant impact on clinical trial recruitment.
  • Continuum Clinical is a global clinical trial enrollment company, providing fact-based patient recruitment solutions that deliver results.
  • We specialize in identifying and solving challenges that can impact successful clinical trial enrollment, from protocol development through study completion.

2020 Global Low Back Pain Clinical Trials Review - Region, Country, Trial Status, Trial Phase, Sponsor Type & End Point Status - ResearchAndMarkets.com

Friday, March 13, 2020 - 4:20pm

The "Low Back Pain Global Clinical Trials Review, H1, 2020" clinical trials has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Low Back Pain Global Clinical Trials Review, H1, 2020" clinical trials has been added to ResearchAndMarkets.com's offering.
  • This clinical trial report, Low Back Pain Global Clinical Trials Review, H1, 2020" provides an overview of Low Back Pain Clinical trials scenario.
  • This report provides top line data relating to the clinical trials on Low Back Pain.
  • The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type.